跳至主要内容
临床试验/NCT03064932
NCT03064932已完成不适用

The Effect of Chronic Consumption of Popular Spices on Risk Factors for Cardiovascular Disease (CVD), Inflammation & Immune Function, and Diet Satisfaction

Penn State University2 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2017年1月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
71
试验地点
2
主要终点
Change in lipid/lipoprotein profile

研究概览

简要总结

This study is a randomized 3-period crossover, controlled feeding study designed to evaluate the effects of the most commonly consumed spices in the U.S. on CVD risk factors, inflammation & immune function, and diet satisfaction in participants at risk for CVD.

详细描述

A 3-period randomized crossover controlled-feeding study will be conducted. Participants will be randomly assigned to receive each 4-week treatment (diet) in random order. Each test diet period will be separated by a standard 4-week compliance break. Data collection will be conducted across at baseline (start of study) and the end of each diet period to assess the effects of chronic spice consumption on selected cardiovascular endpoints.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • overweight or obese (25-35kg/m2)
  • non-smoking
  • male or female
  • waist circumference >= 94cm for men and >=80cm for women
  • at least one other of the following: LDL- cholesterol >130mg/dL; CRP >1mg/L; triglycerides >=150mg/dL; HDL <40mg/dL for men or <50mg/dL for women; systolic blood pressure >= 130mmHg or diastolic >= 85mmHg; fasting glucose >=100mg/dL

排除标准

  • diabetes (fasting glucose >126mg/dL)
  • hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
  • prescribed anti-hypertensive or glucose lowering drugs
  • established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease
  • use of cholesterol/lipid lowering medication or supplementation (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals
  • pregnancy or lactation
  • weight loss of >=10% of body weight within the 6 months prior to enrolling in the study
  • vegetarianism

结局指标

主要结局

Change in lipid/lipoprotein profile

时间窗: Change from baseline in lipid/lipoprotein profile at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16)

Total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides

次要结局

  • Diet satisfaction(After each 4 week diet period)
  • Change in Glucose(Change from baseline in glucose at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • HDL function(Change from baseline in lipid/lipoprotein profile at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Change in flow mediated dilation(Change from baseline in flow mediated dilation at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Change in lipoprotein particle size and subclasses(Change lipoprotein particle size and subclasses at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Central blood pressure(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Brachial blood pressure(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Augmentation index(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Pulse wave velocity(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Change in Insulin(Change from baseline in insulin at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Inflammation and immune fuction(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • Ambulatory blood pressure(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))
  • in vitro production of inflammatory cytokines and immune markers(Change from baseline at the end of diet period 1 (week 4), diet period 2 (week 10), diet period (week 16))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验